Folfirinox: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Folfirinox

• Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
  NCT06483555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
  NCT03484299 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
  NCT05462496 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
  NCT05132504 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
  NCT06384560 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
  NCT05482893 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
  NCT04084496 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Folfirinox?

7 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.